News tagged with atherosclerotic cardiovascular disease

More evidence evolocumab exceeds cost-effectiveness

(HealthDay)—At its current price, the addition of evolocumab to standard therapy in patients with atherosclerotic cardiovascular disease generally exceeds accepted cost-effectiveness thresholds, according to a study published ...

Aug 25, 2017
popularity0 comments 0

Estimating cost when it comes to novel therapies

When it comes to patient care, finding the best treatment can sometimes include finding an equal, yet more economical solution. Rather than introducing a costly new medication, for some patients changing current dosages or ...

May 17, 2017
popularity0 comments 0

Subscribe to rss feed